Specialty drugs are an increasing worry for health plans and employers as new and innovative therapies enter the U.S. market and patients flock to them.
Since 2019, tennis participation in the U.S. has grown by 54 percent. The surge in tennis playing that started during the COVID-19 pandemic has persisted.
Over the last few decades, physicians are increasingly pursuing subspecialty training.
Excessive napping may indicate serious metabolic health issues.
AI‑designed intracellular antibody fragments can stay stable inside cells and bind misfolded proteins, opening new treatment routes for diseases.
Membership medicine is booming. Medicare’s new APCM codes, combined with technology-enabled care delivery partners, offer a path to scale concierge-style care beyond those who can afford it.
The burnout crisis in healthcare continues to escalate.
Peptides are everywhere—from longevity clinics to social media. But not everyone is qualified to give advice. Here’s what to know before you trust the trend.
The 49ers investigated a conspiracy theory—not to validate it, but to remove doubt. A lesson for leaders navigating uncertainty, risk and decisionmaking.
New JAMA studies examine whether routine colonoscopies and low‑dose thyroid drugs benefit older adults, raising questions about risks, costs and continued use.